BOULDER, Colo., May 5, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Bank of America Merrill Lynch Healthcare Conference in Las Vegas. The public is welcome to participate in the conferences through a webcast on the Array BioPharma website. 




    Event:                         Bank of America Merrill Lynch
     Healthcare Conference

    Date:                           Tuesday, May 10, 2016

    Time:                          3:00 p.m. PDT

    Location:                    Encore at the Wynn, Las Vegas, NV

    Webcast:                    investor.arraybiopharma.com

About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.



    CONTACT:                        Tricia Haugeto

                                    Array BioPharma Inc

                                    303-386-1193

                                    thaugeto@arraybiopharma.com

http://photos.prnewswire.com/prnvar/20121029/LA02195LOGO

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-bank-of-america-merrill-lynch-healthcare-conference-300264159.html

SOURCE Array BioPharma Inc.